Simplex Trading
BCYC

Simplex Trading’s Bicycle Therapeutics BCYC Stock Holding History

Simplex Trading’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.05M Buy
248,700
+64,700
+35% +$297K ﹤0.01% 2718
2026
Q1 		$854K Buy
184,000
+173,000
+1,573% +$989K ﹤0.01% 2676
2025
Q4 		$77.9K Buy
11,000
+10,100
+1,122% +$74.5K ﹤0.01% 5250
2025
Q3 		$6K Sell
900
-100
-10% -$755 ﹤0.01% 8160
2025
Q2 		$6K Sell
1,000
-2,100
-68% -$16.7K ﹤0.01% 7618
2025
Q1 		$26K Buy
3,100
+2,500
+417% +$29.5K ﹤0.01% 6353
2024
Q4 		$8K Buy
600
+400
+200% +$8.57K ﹤0.01% 7306
2024
Q3 		$4K Hold
200
– – ﹤0.01% 7687
2024
Q2 		$4K Buy
200
+100
+100% +$2.26K ﹤0.01% 7947
2024
Q1 		$2K Sell
100
-63,600
-100% -$1.35M ﹤0.01% 8362
2023
Q4 		$1.15M Sell
63,700
-3,700
-5% -$61.2K ﹤0.01% 2881
2023
Q3 		$1.35M Buy
67,400
+6,800
+11% +$155K ﹤0.01% 2397
2023
Q2 		$1.55M Buy
60,600
+47,400
+359% +$1.1M ﹤0.01% 2192
2023
Q1 		$280K Sell
13,200
-700
-5% -$17.6K ﹤0.01% 3919
2022
Q4 		$411K Buy
13,900
+13,100
+1,638% +$351K ﹤0.01% 3380
2022
Q3 		$18K Buy
800
+100
+14% +$2.38K ﹤0.01% 7611
2022
Q2 		$11K Buy
+700
New +$14.8K ﹤0.01% 8182
2022
Q1 		– Sell
-1,400
Closed -$85K – 10378
2021
Q4 		$85K Buy
+1,400
New +$77.2K ﹤0.01% 6496

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
GP
GSK plc London $602M AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Simplex Trading's BCYC Position: Q2 2026 in Review

Simplex Trading opened a new position in Bicycle Therapeutics (BCYC) in Q2 2026: 35,232 shares worth $149K. The stake represents ﹤0.01% of the portfolio and ranks #5081 among its holdings. This is a return to the name: Simplex Trading previously reported a position in BCYC as recently as Q4 2025.

Simplex Trading first reported a position in BCYC in Q4 2021 and has held it in 13 quarters since. The position peaked at $1.7M in Q2 2023. 104 funds tracked by Wall St. Rank hold BCYC as of Q2 2026.

  • Simplex Trading held 35,232 shares of Bicycle Therapeutics worth $149K as of Q2 2026.
  • Bicycle Therapeutics was a new Simplex Trading position in Q2 2026.
  • Bicycle Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #5081 holding.
  • Simplex Trading first reported a position in Bicycle Therapeutics in Q4 2021 and has held it in 13 quarters since.
  • Simplex Trading's Bicycle Therapeutics position peaked at $1.7M in Q2 2023.
  • 104 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.